ijms-logo

Journal Browser

Journal Browser

The Roles of Diet and Nutrition in Metabolic Diseases: Advancements in Molecular Insights

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 20 October 2025 | Viewed by 692

Special Issue Editor


E-Mail Website
Guest Editor
Medicine and Psychology School, Autonomous University of Baja California, Universidad 14418, UABC, Parque Internacional Industrial Tijuana, Tijuana 22390, BC, Mexico
Interests: nutrition; obesity; diet; chronic diseases; genetics

Special Issue Information

Dear Colleagues,

Metabolic diseases, including obesity, type 2 diabetes, cardiovascular disease, dyslipidemia, and metabolic dysfunction-associated steatotic liver disease, constitute a global public health problem. In addition to sedentarism and emotional stress, diets high in fat, sugar, and sodium and deficient in fiber and essential micronutrients significantly contribute to the prevalence of these diseases. Advances in omics sciences, such as genomics (genetic background), epigenomics (epigenetic marks), metagenomics (gut microbiota composition), metabolomics (metabolic fingerprints), and proteomics (protein profiles), help to clarify the molecular mechanisms underlying the development of these pathologies and their relationship with diet and nutrition. These findings also enable the design of personalized intervention strategies to improve the nutritional management of metabolic diseases. This Special Issue covers observational or animal evidence pertaining to the impact of diet and nutrition on the occurrence of metabolic diseases, with an emphasis on molecular research. Clinical trials that focus on the use of dietary interventions for the treatment of metabolic diseases and incorporate molecular insights are welcome. We additionally seek comprehensive reviews that explore key advances in understanding the role of nutrition in metabolic diseases at the molecular level. Studies combining the use of different omics tools will particularly be considered.

Dr. Ramos-López Omar
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • diet
  • nutrition
  • metabolic diseases
  • obesity
  • genetics
  • microbiota
  • epigenetics
  • metabolomics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 1426 KB  
Review
Dietary and Pharmacological Modulation of Aging-Related Metabolic Pathways: Molecular Insights, Clinical Evidence, and a Translational Model
by Antonio Fernando Murillo-Cancho, David Lozano-Paniagua and Bruno José Nievas-Soriano
Int. J. Mol. Sci. 2025, 26(19), 9643; https://doi.org/10.3390/ijms26199643 - 2 Oct 2025
Viewed by 489
Abstract
Advances in geroscience suggest that aging is modulated by molecular pathways that are amenable to dietary and pharmacological intervention. We conducted an integrative critical review of caloric restriction (CR), intermittent fasting (IF), and caloric restriction mimetics (CR-mimetics) to compare shared mechanisms, clinical evidence, [...] Read more.
Advances in geroscience suggest that aging is modulated by molecular pathways that are amenable to dietary and pharmacological intervention. We conducted an integrative critical review of caloric restriction (CR), intermittent fasting (IF), and caloric restriction mimetics (CR-mimetics) to compare shared mechanisms, clinical evidence, limitations, and translational potential. Across modalities, CR and IF consistently activate AMP-activated protein kinase and sirtuins, inhibit mTOR (mechanistic target of rapamycin) signaling, and enhance autophagy, aligning with improvements in insulin sensitivity, lipid profile, low-grade inflammation, and selected epigenetic aging measures in humans. CR-mimetics, such as metformin, resveratrol, rapamycin, and spermidine, partially reproduce these effects; however, long-term safety and efficacy in healthy populations remain incompletely defined. Methodological constraints—short trial duration, selective samples, intermediate (nonclinical) endpoints, and limited adherence monitoring—impede definitive conclusions on hard outcomes (frailty, disability, hospitalization, mortality). We propose the Active Management of Aging and Longevity (AMAL) model, a three-level biomarker-guided framework that integrates personalized diet, chrono-nutrition, exercise, and the selective use of CR-mimetics, along with digital monitoring and decision support. AMAL emphasizes epigenetic clocks, multi-omics profiling, inflammatory and microbiome metrics, and adaptive protocols to enhance adherence and clinical relevance. Overall, CR, IF, and CR mimetics constitute promising, complementary strategies to modulate biological aging; rigorous long-term trials with standardized biomarkers and clinically meaningful endpoints are needed to enable their scalable implementation. Full article
Show Figures

Graphical abstract

Back to TopTop